Search research articles
Contact Us
Filters
Showing results (561-570 of 674) with videos related to
Page
of 68
Sort By:
Cell Death and Differentiation
|
June 17, 2017
TGFβ pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis
Patrizia Cammareri, David F Vincent, Michael C Hodder, et al.
Structure (London, England : 1993)
|
January 17, 2004
Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor
Richard A Norman, Simon T Barry, Michael Bate, et al.
Molecular Cancer Therapeutics
|
June 9, 2012
MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo
David W Jenkins, Sarah Ross, Margaret Veldman-Jones, et al.
Oncogene
|
October 31, 2012
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo
C Eberlein, J Kendrew, K McDaid, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers
Janet K Horton, Rachel C Blitzblau, Sua Yoo, et al.
The Oncologist
|
October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
Sara M Tolaney, David R Ziehr, Hao Guo, et al.
Nature Communications
|
November 9, 2016
An enduring rapidly moving storm as a guide to Saturn's Equatorial jet's complex structure
A Sánchez-Lavega, E García-Melendo, S Pérez-Hoyos, et al.
Frontiers in Oncology
|
February 11, 2026
Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinoma
Anna M Reagan, Hannah G McDonald, Jaewon Kang, et al.
Cancer Research
|
October 16, 2024
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition
Sigrid K Fey, Arafath K Najumudeen, Dale M Watt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians
Jeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
Page
of 68
Search research articles
Search
Showing results (561-570 of 674) with videos related to
Sort By:
Page
of 68
Cell Death and Differentiation
|
June 17, 2017
TGFβ pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis
Patrizia Cammareri, David F Vincent, Michael C Hodder, et al.
Structure (London, England : 1993)
|
January 17, 2004
Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor
Richard A Norman, Simon T Barry, Michael Bate, et al.
Molecular Cancer Therapeutics
|
June 9, 2012
MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo
David W Jenkins, Sarah Ross, Margaret Veldman-Jones, et al.
Oncogene
|
October 31, 2012
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo
C Eberlein, J Kendrew, K McDaid, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2015
Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers
Janet K Horton, Rachel C Blitzblau, Sua Yoo, et al.
The Oncologist
|
October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
Sara M Tolaney, David R Ziehr, Hao Guo, et al.
Nature Communications
|
November 9, 2016
An enduring rapidly moving storm as a guide to Saturn's Equatorial jet's complex structure
A Sánchez-Lavega, E García-Melendo, S Pérez-Hoyos, et al.
Frontiers in Oncology
|
February 11, 2026
Case Report: Prolonged response to cabozantinib and pembrolizumab in treatment-refractory metastatic pancreatic ductal adenocarcinoma
Anna M Reagan, Hannah G McDonald, Jaewon Kang, et al.
Cancer Research
|
October 16, 2024
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition
Sigrid K Fey, Arafath K Najumudeen, Dale M Watt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians
Jeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
Page
of 68